FDA Panel: Thumbs Up for Pfizer/BioNTech COVID Vax

(MedPage Today) -- An FDA advisory committee voted to recommend the Pfizer-BioNTech mRNA COVID-19 vaccine candidate (BNT162b2) for use in individuals age 16 or older, though there was some late-breaking drama at the end of the meeting.
Based on...